| 1 |
33190426 | Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm. | 2021 Mar |
2 |
| 2 |
33458528 | Human Hexa-Histidine-Tagged Single-Chain Variable Fragments for Bioimaging of Bacterial Infections. | 2021 Jan 12 |
1 |
| 3 |
31691197 | Anti-HER2 scFv Expression in Escherichia coli SHuffle®T7 Express Cells: Effects on Solubility and Biological Activity. | 2020 Jan |
2 |
| 4 |
31181988 | Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. | 2019 Aug/Sep |
1 |
| 5 |
30130449 | Characterization and analysis of scFv-IgG bispecific antibody size variants. | 2018 Nov-Dec |
5 |
| 6 |
28340507 | Understanding the contribution of disulfide bridges to the folding and misfolding of an anti-Aβ scFv. | 2017 Jun |
2 |
| 7 |
28423625 | Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer. | 2017 Mar 21 |
1 |
| 8 |
24895182 | Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy. | 2015 Jan 15 |
1 |
| 9 |
25523746 | Nanocell targeting using engineered bispecific antibodies. | 2015 |
1 |
| 10 |
25256416 | Co-expression of Dsb proteins enables soluble expression of a single-chain variable fragment (scFv) against human type 1 insulin-like growth factor receptor (IGF-1R) in E. coli. | 2014 Dec |
1 |
| 11 |
25478966 | Anti-CTGF single-chain variable fragment dimers inhibit human airway smooth muscle (ASM) cell proliferation by down-regulating p-Akt and p-mTOR levels. | 2014 |
3 |
| 12 |
22138455 | Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit. | 2012 Jul 1 |
1 |
| 13 |
22464987 | Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition. | 2012 Oct 15 |
1 |
| 14 |
22484084 | A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency. | 2012 Jun |
1 |
| 15 |
22907349 | Selection of stable scFv antibodies by phage display. | 2012 |
1 |
| 16 |
20019028 | A modular IgG-scFv bispecific antibody topology. | 2010 Apr |
3 |
| 17 |
20068035 | Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries. | 2010 Mar 12 |
1 |
| 18 |
20424732 | Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF. | 2010 Jul |
1 |
| 19 |
21339972 | Stabilization of the single-chain fragment variable by an interdomain disulfide bond and its effect on antibody affinity. | 2010 Dec 23 |
3 |
| 20 |
19099209 | Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells. | 2009 Jun |
1 |
| 21 |
18795288 | High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli. | 2008 Nov |
1 |
| 22 |
12831531 | Minimal structural elements of an inhibitory anti-ATF1/CREB single-chain antibody fragment (scFv41.4). | 2003 Apr |
1 |
| 23 |
11105248 | Efficient heterodimerization of recombinant bi- and trispecific antibodies. | 2000 |
1 |
| 24 |
11120833 | Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives. | 2000 Dec 15 |
2 |
| 25 |
10390351 | Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation. | 1999 Jul 9 |
2 |
| 26 |
9637257 | An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly. | 1998 May 15 |
8 |
| 27 |
9761676 | The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge. | 1998 |
1 |
| 28 |
9026037 | Optimization of conditions for formation and analysis of anti-CD19 FVS191 single-chain Fv homodimer (scFv')2. | 1997 Jan-Feb |
1 |
| 29 |
9404661 | Generation and characterization of an anti-CD19 single-chain Fv immunotoxin composed of C-terminal disulfide-linked dgRTA. | 1997 Nov-Dec |
3 |